Related Experiment Video
Updated: Aug 30, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and explantation
Robert Saeid Farivar1, Lawrence H Cohn
1Division of Cardiac Surgery, Department of Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Insights
High cholesterol may increase the risk of bioprosthetic valve calcification and the need for valve replacement. This study found a link between elevated serum cholesterol and explanted valves.
Area of Science:
- Cardiovascular Medicine
- Biomaterials Science
- Pathology
Background:
- Bioprosthetic valve calcification shares pathophysiologic similarities with atherosclerosis.
- Understanding risk factors for calcification is crucial for improving bioprosthetic valve longevity.
Purpose of the Study:
- To investigate the association between atherosclerosis risk factors and calcification and dysfunction in explanted bioprosthetic valves.
- To determine if elevated serum cholesterol levels are linked to bioprosthetic valve calcification requiring explantation.
Main Methods:
- Retrospective cohort study of 144 patients with explanted bioprosthetic valves, assessing calcification and serum cholesterol.
- Case-control analysis comparing 66 explanted valves with 66 matched controls.
- Univariate and stepwise multiple regression analyses were performed.
Main Results:
- Univariate analysis identified cholesterol, younger age at implantation, and coronary artery disease as linked to calcification.
- Stepwise regression revealed mean serum cholesterol level as the sole significant predictor of calcification (P =.02).
- Patients with explanted valves had significantly higher mean serum cholesterol (189 vs 163 mg/dL, P <.0001). Odds ratio for explantation was 3.9 for cholesterol > 200 mg/dL.
Conclusions:
- Elevated serum cholesterol level is a significant risk factor for bioprosthetic valve calcification.
- Higher cholesterol levels are associated with an increased likelihood of requiring bioprosthetic valve explantation.
- These findings suggest cholesterol management may be important in preserving bioprosthetic valve function.
Objective:
There are pathophysiologic similarities between calcification and atherosclerosis. We wished to determine whether risk factors for atherosclerosis were linked to bioprosthetic valve calcification and dysfunction.
Methods:
We performed a retrospective cohort study on 144 patients at a single institution who had bioprosthetic aortic or mitral valves removed, serum cholesterol levels recorded, and valve calcification assessed on the basis of hematoxylin and eosin staining and radiography of the valve. We also performed case-control analysis of a group of 66 patients whose tissue valves were explanted and compared them with an age- and position-matched group of 66 patients with similar duration of implantation. We also compared mean serum cholesterol levels.
Results:
In the retrospective cohort study cholesterol (P =.035), younger age at implantation (P =.014), and coronary artery disease (P =.017) were linked to calcification of the valve by means of univariate analysis. In stepwise multiple regression analysis only the mean serum cholesterol level was linked to calcification (P =.02). Sex, hypertension, smoking, diabetes, and implant position were not linked to calcification. In the case-control analysis the mean serum cholesterol level of the explanted valve group was significantly higher (189 vs 163 mg/dL, P <.0001) than that of the group whose valves did not require explantation. For those whose serum cholesterol levels were greater than 200 mg/dL, the odds ratio was 3.9 (95% confidence interval, 1.7-8.9) for valve explantation.
Conclusions:
Increased serum cholesterol level may be a risk factor for bioprosthetic valve calcification requiring explantation.
Related Concept Videos
Cholecystitis
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Mitral Valve Prolapse I: Introduction
Atherosclerosis I: Introduction
Mitral Stenosis I: Introduction
